Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
Birkeland
S A
SA
Department of Nephrology, University Hospital, Odense, Denmark.
Svendsen
V
V
Rohr
N
N
Hansen
B L
BL
Elbirk
A
A
Foged
N
N
Køhler
F
F
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000276:immunology / Q000627:therapeutic use*; D002648:Child; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008875:Middle Aged; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents